Level three gene expression data from the TCGA lung SqCC and ADC cohorts were ranked by differential expression (in normalized TPM), P<0.05 with false discovery rate (FDR) < 5%, and a minimum fold change of two between SqCC and ADC. Identified DEGs were then compared to normal tissue to ensure normal/tumor differential expression. 
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Supplementary Figure 10 Lung SqCC cells are selectively susceptible to glycolytic inhibition. (a, b)
Flow cytometry of cell viability assay using Annexin V-PE and 7-AAD after treatment with glycolytic inhibitor, 2-DG (25mM) (a) and GLUT1 inhibitor, WZB117 (50μM) (b) for 48-72 hours (n=5 each group from at least three biologically independent experiments). Comparison of representative H&E stained tissues of brain, muscle, lung, heart, liver, kidney, and pancreas of vehicle (n=3) and WZB117 (n=3) treated mice after 3 weeks of treatment (10mg/kg daily). Scale bars, 100µM.
